Beyond the Beat: Navigating Trends in Hypertrophic Cardiomyopathy Treatment
The hypertrophic cardiomyopathy therapeutics market was estimated at USD 1.3 billion in 2020 and is likely to grow at a CAGR of 2.4% during 2021-2026 to reach USD 1.49 billion in 2026.
Hypertrophic cardiomyopathy is referred to as a disorder where the heart muscle becomes abnormally thick or hypertrophied.
Read More: https://www.stratviewresearch.....com/2653/hypertrophi
Like
Comment
Share
